About Mifegymiso


About Mifegymiso

MIFEGYMISO (Mifepristone/Misoprostol) is a combination pack of two (2) medications used for ending your pregnancy. This is called an abortion. Mifegymiso is a non-surgical option for early abortion. Mifegymiso is only used if your last period started 63 days ago or less.

Before you take Mifegymiso:

  • You will get counselling. Your health professional will tell you about:
    • The chance of bleeding
    • The chance of infection
    • The chance of an incomplete abortion
    • How to access the treatment centre by telephone or local access
  • You should give your informed consent to take Mifegymiso
  • You may get an ultrasound scan
  • You will get a printed copy of the Mifegymiso:
    • Patient Medication Information
    • Patient Information Card that was completed by the health professional.

Want more information about Mifegymiso

  • Talk to your health professional
  • Find the full product monograph that is prepared for health professionals and includes this Patient Medication Information by visiting the Health Canada website,
  • You can also download the product monograph from this site, or request a copy by calling 1-877-230-4227.
  • Ask your health professional if you qualify for Mifegymiso universal coverage. (not applicable in all provinces and territories)

Patient Support

Patients can find out how and where to access abortion providers across Canada by talking to their health professional or logging on to ACTION CANADA FOR SEXUAL HEALTH AND RIGHTS, https://www.sexualhealthandrights.ca/Action Canada for Sexual Health and Rights is a progressive, pro-choice charitable organization committed to advancing and upholding sexual and reproductive health and rights in Canada and globally. Among other national and international programming, Action Canada runs a 24/7 toll-free access line for abortion referrals and a public online directory.  If you require assistance from Action Canada please call their toll-free access line at 1-888-642-2725.

Patients can also refer to NAF: The National Abortion Federation (NAF) is the professional association of abortion providers. NAF members include clinics,  and physicians who together care for more than half of the women who choose abortion in Canada each year. NAF sets the standards for quality abortion care through their evidence-based Clinical Policy Guidelines for Abortion Care, and provides continuing medical education in all aspects of abortion care. NAF Canada works to ensure that abortion care is safe, legal, and accessible.  http://www.nafcanada.org/


Mifegymiso Q&A Click Here

Please read this information carefully. We encourage you to ask your health professional questions about the information provided. You may also wish to discuss the information in this Q & A with a friend or family member.

Product Monograph
View file
Patient Information Brochure
View file
Patient Medication Insert
View file
Mifepristone ਅਤੇMisoprostol ਗਰਭ-ਅਵਸਥਾ ਦੇਮੈਡੀਕਲ ਖਾਤਮੇ ਲਈ
View file
Misoprostolو Mifepristone ّ لإنھاء الحمل الطبي
View file
Mifepristone和Misoprostol 药物终止妊娠
View file

Mifegymiso Facts

  • Mifepristone and misoprostol have been used for the termination of first trimester pregnancy since the 1980s.
  • Mifepristone and misoprostol are approved for use in more than 60 countries including USA, UK, Australia, France and New Zealand.
  • Mifegymiso (Mifepristone and Misoprostol combo pack) is the only medication approved as a non-surgical option for early abortion in Canada.  The World Health Organization (WHO), the worlds leading health body includes Mifepristone/ Misoprostol combination to its list of essential medicines.

DISCLAIMER: The information provided on this website is for general information only.

Celopharma Inc. and it's affiliates makes every effort to ensure the accuracy and reliability of the information that appears on it's website but cannot guarantee that it is error free or complete.

© Celopharma Inc. All rights reserved.